Franz Kainz

Franz Kainz is a seasoned professional in the pharmaceutical industry with extensive experience in B2B operations and contract development and manufacturing. Currently serving as Senior Vice President of B2B Operations at Fresenius Kabi since May 2017, Kainz oversees two API manufacturing sites in Austria and Italy and leads global CDMO operations for sterile drug products across multiple production facilities. Previous roles include Senior Vice President of FP CMO and Vice President of Contract Manufacturing for Evonik Nutrition & Care GmbH, demonstrating expertise in managing substantial budgets and complex parenteral formulations. Kainz has a robust academic background, holding a Ph.D. in Developmental Genetics from the University of Cambridge and experience as a PostDoc at Harvard University.